Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice

Canadian Journal of Anesthesia

Volumn 51, Issue 6, 2004, Pages 566-572

  de Araujo, Daniele R ^a   Cereda, Cíntia M S ^a   Brunetto, Giovana B ^a   Pinto, Luciana M A ^a   Santana, Maria Helena A ^a   de Paula, Eneida ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BUPIVACAINE; CHOLESTEROL; LIPOSOME; LOCAL ANESTHETIC AGENT; MEPIVACAINE; PHOSPHATIDYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; ENCAPSULATION; IN VIVO STUDY; INJECTION SITE; LIPID SOLUBILITY; MOTOR PERFORMANCE; MOUSE; NERVE BLOCK; NONHUMAN; PAIN; PRIORITY JOURNAL; SCIATIC NERVE; STATISTICAL ANALYSIS;

EID: 3042783339     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03018399     Document Type: Article

References (28)

1. Covino BG. Pharmacology of local anaesthctic agents. Br J Anaesth 1986; 58: 701-16.
2. Collins VJ. Principles of Anesthesiology. General and Regional Anesthesia. New York: Lea & Febiger; 1993.
3. Kuzma PJ, Kline MD, Calkins MD, Staats PS. Progress in the development of ultra-long-acting local anesthetics. Reg Anesth 1997; 22: 543-51.
4. de-Paula E, Schreier S. Molecular and physicochemical aspects of local anesthetic-membrane interaction. Braz J Med Biol Res 1996; 29: 877-94.
5. de Paula E, Schreier S. Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure. Biochim Biophys Acta 1995; 1240: 25-33.
6. Fraceto LF, Pinto LM, Franzoni L, et al. Spectroscopic evidence for a preferential location of lidocaine inside phospholipid bilayers. Biophys Chem 2002; 99: 229-43.
7. Pinto LM, Yokaichiya DK, Fraceto LF, de Paula E. Interaction of benzocaine with model membranes. Biophys Chem 2000; 87: 213-23.
8. Mowat JJ, Mok MJ, MacLeod BA, Madden TD. Liposomal bupivacaine. Extended duration nerve blockade using large unilamellar vesicles that exhibit a proton gradient. Anesthesiology 1996; 85: 635-43.
9. Grant GJ, Bansinath M. Liposomal delivery systems for local anesthetics. Reg Anesth Pain Med 2001; 26: 61-3.
10. Leszczynska K, Kau ST. A sciatic nerve blockade method to differentiate drug-induced local anesthesia from neuromuscular blockade in mice. J Pharmacol Toxicol Methods 1992; 27: 85-93.
11. Gantenbein M, Abat C, Attolini L, Pisano P, Emperaire N, Bruguerolle B. Ketamine effects on bupivacaine local anaesthetic activity and pharmacokinetics of bupivacaine in mice. Life Sci 1997; 61: 2027-33.
12. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957; 111: 409-19.
13. a values of clinically used drugs. Anesth Analg 1990; 71: 158-70.
14. Grant GJ, Vermeulin K, Zakowski MI, et al. A rat sciatic nerve model for independent assessment of sensory and motor block induced by local anesthetics. Anesth Analg 1992; 75: 889-94.
15. Simonetti MP, Valinetti EA, Ferreira EM. Evaluation of the local anesthetic activity of S(-) bupivacaine: experimental study in vivo in the rat sciatic nerve (Portuguese). Rev Bras Anestesiol 1997; 47: 425-34.
16. Kohane DS, Lipp M, Kinney RC, Lotan N, Langer R. Sciatic nerve blockade with lipid-protein-sugar particles containing bupivacaine. Pharm Res 2000; 17: 1243-9.
17. Estebe JP, Gentili ME, Le Corre P, Le Verge R, Moulinoux JP, Ecoffey C. Sciatic nerve block with bupivacaine-loaded microspheres prevents hyperalgesia in an inflammatory animal model. Can J Anesth 2002; 49: 690-3.
18. Grant GJ, Zakowski MI, Vermeulen K, Langerman L, Ramanathan S, Turndorf H. Assessing local anesthetic effect using the mouse tail flick test. J Pharmacol Toxicol Methods 1993; 29: 223-6.
19. Grant GJ, Vermeulen K, Langerman L, Zakowski M, Turndorf H. Prolonged analgesia with liposomal bupivacaine in a mouse model. Reg Anesth 1994; 19: 264-9.
20. Grant GJ, Barenholz Y, Piskoun B, Bansinath M, Turndorf H, Bolotin EM. DRV liposomal bupivacaine: preparation, characterization, and in vivo evaluation in mice. Pharm Res 2001; 18: 336-43.
21. Boogaerts JG, Lafont ND, Declercq AG, et al. Epidural administration of liposome-associated bupivacaine for the management of postsurgical pain: a first study. J Clin Anesth 1994; 6: 315-20.
22. a. Br J Anaesth 1987; 59: 379-84.
23. Malinovsky JM, Le Corre P, Meunier JF, et al. A dose-response study of epidural liposomal bupivacaine in rabbits. J Control Release 1999; 60: 111-9.
24. Yu HY, Sun P, Hou WY. Prolonged local anesthetic effect of bupivacaine liposomes in rats. Int J Pharm 1998; 176: 133-6.
25. Boogaerts J, Declercq A, Lafont N, et al. Toxicity of bupivacaine encapsulated into liposomes and injected intravenously: comparison with plain solutions. Anesth Analg 1993; 76: 553-5.
26. Malinovsky JM, Benhamou D, Alafandy M, et al. Neurotoxicological assessment after intracisternal injection of liposomal bupivacaine in rabbits. Anesth Analg 1997; 85: 1331-6.
27. Mui BL, Cullis PR, Evans EA, Madden TD. Osmotic properties of large unilamellar vesicles prepared by extrusion. Biophys J 1993; 64: 443-53.
28. Mui BL, Cullis PR, Pritchard PH, Madden TD. Influence of plasma on the osmotic sensitivity of large unilamellar vesicles prepared by extrusion. J Biol Chem 1994; 269: 7364-70.